
EZPW, PLOW, NVT, ALTO and SLQT have been added to the Zacks Rank #1 (Strong Buy) List on June 15, 2026.
Founded in 1985, SelectQuote (NYSE: SLQT) offers solutions that help consumers protect their most valuable assets - their families, health, and property.
| Revenue (TTM) | $1.64B |
| Gross Profit (TTM) | $576.13M |
| EBITDA | $71.36M |
| Operating Margin | 8.34% |
| Return on Equity | 15.00% |
| Return on Assets | 2.96% |
| Revenue/Share (TTM) | $8.79 |
| Book Value | $2.18 |
| Price-to-Book | 0.36 |
| Price-to-Sales (TTM) | 0.08 |
| EV/Revenue | 0.482 |
| EV/EBITDA | 4.86 |
| Quarterly Earnings Growth (YoY) | 219.20% |
| Quarterly Revenue Growth (YoY) | 5.60% |
| Shares Outstanding | $176.35M |
| Float | $143.70M |
| % Insiders | 11.94% |
| % Institutions | 50.46% |

EZPW, PLOW, NVT, ALTO and SLQT have been added to the Zacks Rank #1 (Strong Buy) List on June 15, 2026.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SelectQuote, Inc. (NYSE: SLQT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at SelectQuote caused the company to misrepresent or fail to disclose that: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers' plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors' plans; (4) that as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) that SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) that, as a result of the foregoing, positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

SelectQuote (SLQT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

SelectQuote (SLQT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, announced today that Chief Financial Officer, Ryan Clement, and Head of Investor Relations, Matt Gunter, will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, beginning at approximately 11:00am ET. Management will also be available for 1x1 and small.

SelectQuote (SLQT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SelectQuote, Inc. (SLQT) Q3 2026 Earnings Call Transcript

SelectQuote (SLQT) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago.

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the third quarter of fiscal year 2026 of $430.9 million compared to consolidated revenue for the third quarter of fiscal year 2025 of $408.2 million. Consolidated net income for the third quarter of fiscal year 2026 was $40.2 million compared to consolidated net income for the third quarter of fiscal year 2025 of $26.0 million. Finally, consolidated Adjusted EBITDA* for the third quarter of fi.